|
Market Cap | 979.71M | EPS (ttm) | -0.48 |
P/E | - | EPS this Y | 119.73% |
Forward P/E | 52.94 | EPS next Y | 445.55% |
PEG | - | EPS past 5Y | -32.70% |
P/S | 4.16 | EPS next 5Y | - |
P/B | 9.11 | EPS Q/Q | 56.65% |
Dividend | - | Sales Q/Q | 30.79% |
Insider Own | 77.22% | Inst Own | 17.01% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.01% | Earnings | May 15/b |
Analyst Recom | 3.00 | Target Price | 29.50 |
Avg Volume | 12.14K | 52W Range | 17.52 - 30.99 |
|
|
|
Nayax Ltd. engages in the operation of a global commerce enablement and payments platform. It offers a complete solution including localized cashless payment acceptance, management suite, and consumer engagement tools, enabling merchants to conduct commerce anywhere, at any time. It operates through the following geographical segments: USA, Europe (excluding UK), UK, Australia, Israel, and Rest of the World. The company was founded by Yair Nechmad, Amir Nechmad, and David Ben Avi on January 16, 2005 and is headquartered in Herzliya, Israel. |
|
|
|
Market Cap | 55.75M | EPS (ttm) | -0.89 |
P/E | - | EPS this Y | 50.28% |
Forward P/E | - | EPS next Y | 88.57% |
PEG | - | EPS past 5Y | -228.44% |
P/S | 3.55 | EPS next 5Y | - |
P/B | 1.59 | EPS Q/Q | 69.59% |
Dividend | - | Sales Q/Q | 935.95% |
Insider Own | 17.68% | Inst Own | 11.77% |
Insider Trans | 32.02% | Inst Trans | -1.40% |
Short Float | 3.29% | Earnings | May 15/b |
Analyst Recom | 1.50 | Target Price | 2.33 |
Avg Volume | 224.22K | 52W Range | 0.31 - 2.14 |
|
|
|
Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Marlborough, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Popolo Joseph V | 10% Owner | Feb 26 '24 | Buy | 1.12 | 1,785,714 | 2,000,000 | 3,183,244 | Feb 28 04:49 PM | COHEN RICHARD M | Director | Nov 22 '23 | Option Exercise | 0.00 | 16,216 | 0 | 58,923 | Nov 24 09:35 PM | Seidl Randy | Director | Nov 22 '23 | Option Exercise | 0.00 | 16,216 | 0 | 43,275 | Nov 24 09:37 PM | SOOD JASPREET K | Director | Nov 22 '23 | Option Exercise | 0.00 | 16,216 | 0 | 42,003 | Nov 24 09:39 PM | Popolo Joseph V | 10% Owner | Nov 22 '23 | Buy | 1.19 | 85,646 | 101,944 | 1,284,245 | Nov 24 08:16 AM |
|
|
|
|
Market Cap | 137.18M | EPS (ttm) | -1.39 |
P/E | - | EPS this Y | -8.75% |
Forward P/E | - | EPS next Y | -6.77% |
PEG | - | EPS past 5Y | 42.97% |
P/S | - | EPS next 5Y | - |
P/B | 4.74 | EPS Q/Q | 48.28% |
Dividend | - | Sales Q/Q | - |
Insider Own | 4.94% | Inst Own | 22.17% |
Insider Trans | 0.00% | Inst Trans | -2.52% |
Short Float | 19.68% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 15.00 |
Avg Volume | 953.26K | 52W Range | 2.59 - 10.27 |
|
|
|
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ. |
|
| |
|
Market Cap | 7.17M | EPS (ttm) | -3.48 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 53.33% |
P/S | 4.03 | EPS next 5Y | - |
P/B | 0.86 | EPS Q/Q | 57.45% |
Dividend | - | Sales Q/Q | -7.82% |
Insider Own | 3.72% | Inst Own | 8.56% |
Insider Trans | 0.00% | Inst Trans | -16.27% |
Short Float | 0.52% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 100.00 |
Avg Volume | 177.28K | 52W Range | 1.12 - 7.12 |
|
|
|
Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment is composed of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Nuzum Charles Lee Sr | Director | Sep 25 '23 | Sale | 3.04 | 10,000 | 30,387 | 24,033 | Sep 27 05:03 PM |
|
|
|
|
Market Cap | 125.40M | EPS (ttm) | -1.41 |
P/E | - | EPS this Y | 61.73% |
Forward P/E | - | EPS next Y | 29.03% |
PEG | - | EPS past 5Y | - |
P/S | 26.23 | EPS next 5Y | - |
P/B | 10.58 | EPS Q/Q | -592.11% |
Dividend | - | Sales Q/Q | - |
Insider Own | 49.22% | Inst Own | 11.61% |
Insider Trans | 0.00% | Inst Trans | 4.87% |
Short Float | 6.77% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 8.50 |
Avg Volume | 100.19K | 52W Range | 3.66 - 35.57 |
|
|
|
PSQ Holdings, Inc. develops a values-aligned platform for consumer members. Its consumer members with traditional American values can connect with and patronize business members whose values align with their own. Customers are able to search for and shop businesses offering products and services both locally and online. It operates through the following segments: Marketplace and Brands. The company was founded in February 2021 and is headquartered in West Palm Beach, FL. |
|
| |
|
Market Cap | 31.96M | EPS (ttm) | -2.58 |
P/E | - | EPS this Y | 22.13% |
Forward P/E | - | EPS next Y | 55.08% |
PEG | - | EPS past 5Y | - |
P/S | 4.50 | EPS next 5Y | - |
P/B | - | EPS Q/Q | -322.15% |
Dividend | - | Sales Q/Q | 98.18% |
Insider Own | 4.31% | Inst Own | 10.82% |
Insider Trans | -1.54% | Inst Trans | 9.70% |
Short Float | 8.56% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 9.33 |
Avg Volume | 621.04K | 52W Range | 1.43 - 5.65 |
|
|
|
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Cranbury, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DEVEER ROBERT K JR | Director | Apr 11 '24 | Buy | 2.12 | 6,000 | 12,703 | 40,845 | Apr 11 04:45 PM | DEVEER ROBERT K JR | Director | Mar 06 '24 | Sale | 2.00 | 11,700 | 23,434 | 34,845 | Mar 07 05:02 PM | WILLS STEPHEN T | Executive VP and CFO/COO | Dec 06 '23 | Sale | 2.51 | 4,998 | 12,563 | 327,522 | Dec 08 05:30 PM | DUNTON ALAN W | Director | Dec 04 '23 | Sale | 2.48 | 200 | 496 | 45,074 | Dec 06 05:02 PM |
|
|
|
|
Market Cap | 149.29M | EPS (ttm) | 0.24 |
P/E | 40.38 | EPS this Y | 3.93% |
Forward P/E | 12.22 | EPS next Y | 13.38% |
PEG | 2.69 | EPS past 5Y | - |
P/S | 2.89 | EPS next 5Y | 15.00% |
P/B | 1.79 | EPS Q/Q | 9422.22% |
Dividend | - | Sales Q/Q | 14.00% |
Insider Own | 18.38% | Inst Own | 42.84% |
Insider Trans | 0.00% | Inst Trans | 1.37% |
Short Float | 0.09% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 14.00 |
Avg Volume | 36.36K | 52W Range | 7.52 - 12.10 |
|
|
|
RADCOM Ltd. is engaged in the provision of cloud-native, network intelligence and service assurance solutions for telecom operators. Its solutions include RADCOM Network Visibility, RADCOM Service Assurance, and RADCOM Network Insights. The company was founded by Yehuda Zisapel, Zohar Zisapel, and Nava Zisapel on July 5, 1985 and is headquartered in Tel Aviv, Israel. |
|
| |
|
Market Cap | 49.01M | EPS (ttm) | -0.91 |
P/E | - | EPS this Y | -5.69% |
Forward P/E | - | EPS next Y | 19.42% |
PEG | - | EPS past 5Y | -134.94% |
P/S | 20.34 | EPS next 5Y | - |
P/B | - | EPS Q/Q | 37.43% |
Dividend | - | Sales Q/Q | -40.52% |
Insider Own | - | Inst Own | 11.28% |
Insider Trans | - | Inst Trans | -9.75% |
Short Float | 1.36% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 4.15 |
Avg Volume | 873.47K | 52W Range | 0.24 - 4.04 |
|
|
|
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in New York, NY. |
|
|
|
Market Cap | 1.06B | EPS (ttm) | -0.34 |
P/E | - | EPS this Y | 39.16% |
Forward P/E | - | EPS next Y | 61.17% |
PEG | - | EPS past 5Y | -20.24% |
P/S | 3.58 | EPS next 5Y | - |
P/B | 2.18 | EPS Q/Q | 73.88% |
Dividend | - | Sales Q/Q | 6.01% |
Insider Own | 49.13% | Inst Own | 35.63% |
Insider Trans | 0.00% | Inst Trans | -2.06% |
Short Float | 1.43% | Earnings | May 15/b |
Analyst Recom | 2.33 | Target Price | 5.84 |
Avg Volume | 586.05K | 52W Range | 3.48 - 5.64 |
|
|
|
Riskified Ltd. engages in fraud prevention solutions. It empowers businesses to realize the full potential of eCommerce by making it safe, accessible, and frictionless. The firm operates an electronic commerce risk management platform that allows online merchants to create trusted relationships with its customers. The company was founded by Eido Gal and Assaf Feldman in November 26, 2012 and is headquartered in Tel Aviv, Israel. |
|
|
|
Market Cap | 44.81M | EPS (ttm) | 0.17 |
P/E | 11.08 | EPS this Y | -71.43% |
Forward P/E | 15.42 | EPS next Y | 100.00% |
PEG | - | EPS past 5Y | - |
P/S | 0.17 | EPS next 5Y | - |
P/B | 1.54 | EPS Q/Q | 693.51% |
Dividend | - | Sales Q/Q | 0.71% |
Insider Own | 62.52% | Inst Own | 9.87% |
Insider Trans | -7.38% | Inst Trans | 34.33% |
Short Float | 0.72% | Earnings | May 15/b |
Analyst Recom | 1.00 | Target Price | 7.00 |
Avg Volume | 310.01K | 52W Range | 0.70 - 1.97 |
|
|
|
SPAR Group, Inc. operates as a global merchandising and brand marketing services company, which engages in providing a broad range of sales enhancing services to retailers across most classes of trade, and consumer goods manufacturers and distributors around the world. It operates through the Americas, Asia-Pacific, and Europe, Middle East, and Africa (EMEA) geographical segments. The Americas segment includes the United States, Canada, Brazil, and Mexico. The Asia-Pacific segment refers to Japan, China, India, and Australia. The EMEA segment is involved in South Africa. The company was founded by Robert G. Brown and William H. Bartels in 1967 and is headquartered in Auburn Hills, MI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BARTELS WILLIAMS H | Director | May 09 '24 | Sale | 1.80 | 1,000,000 | 1,800,000 | 4,709,837 | May 13 04:01 PM | SPAR Business Services Inc | Affiliated with Robert G Brown | Apr 01 '24 | Sale | 1.38 | 150,000 | 206,252 | 1,065,538 | Apr 03 02:37 PM | BROWN ROBERT G/ | 10% Owner | Apr 01 '24 | Sale | 1.35 | 50,000 | 67,500 | 3,257,963 | Apr 03 02:49 PM | SPAR Business Services Inc | Affiliated with Robert G Brown | Mar 18 '24 | Sale | 1.03 | 443 | 456 | 1,215,538 | Mar 20 01:04 PM | BROWN ROBERT G/ | 10% Owner | Mar 13 '24 | Sale | 1.03 | 200 | 206 | 3,397,963 | Mar 15 05:04 PM |
|
|
|